130 related articles for article (PubMed ID: 29135538)
21. Adapting the Australian system: is an organized screening program feasible in Malaysia?--an overview of cervical cancer screening in both countries.
Rashid RM; Dahlui M; Mohamed M; Gertig D
Asian Pac J Cancer Prev; 2013; 14(3):2141-6. PubMed ID: 23679334
[TBL] [Abstract][Full Text] [Related]
22. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
24. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
25. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
[TBL] [Abstract][Full Text] [Related]
26. [Cervical cancer screening in the Bas-Rhin. Evaluation of four and a half years of the EVE campaign].
Fender M; Schaffer P; Dellenbach P
Sante Publique; 2000 May; 12 Spec No():11-20. PubMed ID: 10989625
[TBL] [Abstract][Full Text] [Related]
27. [Cervical cancer screening campaign in Doubs: evaluation of the first three years of the pilot program].
Gautier CP; Monnet E; Meslans Y
Sante Publique; 2000 May; 12 Spec No():37-43. PubMed ID: 10989627
[TBL] [Abstract][Full Text] [Related]
28. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
[TBL] [Abstract][Full Text] [Related]
29. Cytological screening for cervical cancer in the province of Limburg, Belgium.
Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
[TBL] [Abstract][Full Text] [Related]
30. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia.
Brotherton JM; Mullins RM
Cancer Epidemiol; 2012 Jun; 36(3):298-302. PubMed ID: 22204834
[TBL] [Abstract][Full Text] [Related]
31. [Participation of women in cervical cancer screening. Results of the first 5 years of a pilot program in the province of Doubs].
Monnet E; Carbillet JP; Meslans Y; Petitjean A; Gautier CP
Presse Med; 1999 Dec; 28(38):2093-7. PubMed ID: 10613195
[TBL] [Abstract][Full Text] [Related]
32. [Cervical cancer in Bas-Rhin: trend and prediction of the incidence in 2014].
Eilstein D; Hédelin G; Schaffer P
J Gynecol Obstet Biol Reprod (Paris); 2002 Feb; 31(1):28-33. PubMed ID: 11976574
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.
Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C
Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451
[TBL] [Abstract][Full Text] [Related]
34. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
35. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
[TBL] [Abstract][Full Text] [Related]
36. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
White MC; Shoemaker ML; Benard VB
Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
[TBL] [Abstract][Full Text] [Related]
37. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
38. [Prevention and screening of cervical cancer].
Rakotomahenina H; Garrigue I; Marty M; Brun JL
Rev Prat; 2014 Jun; 64(6):780-5. PubMed ID: 25090760
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
40. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
